These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37442821)

  • 21. Comparison of hematopoietic stem cell transplantation and repeated intensified immunosuppressive therapy as second-line treatment for relapsed/refractory severe aplastic anemia.
    Zhang L; Li J; Liang W; Zhang X; Chen S; Shi Y; Hao M; Zhao X; Gong M; Wei J; He Y; Jiang E; Han M; Zhang F; Feng S
    Front Immunol; 2024; 15():1425076. PubMed ID: 39221245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparisons Between Frontline Therapy and a Combination of Eltrombopag Plus Immunosuppression Therapy and Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation in Patients With Severe Aplastic Anemia: A Systematic Review.
    Yang Y; Ji J; Tang Z; Han B
    Front Oncol; 2021; 11():614965. PubMed ID: 33981596
    [No Abstract]   [Full Text] [Related]  

  • 23. [Haploidentical Hematopoietic Stem Cell Transplantation with Co-Infusion of Mesenchymal Stromal Cells for Acquired Severe Aplastic Anemia: A Report of 127 Cases].
    Han DM; Ding L; Zheng XL; Yan HM; Xue M; Liu J; Zhu L; Li S; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1230-1237. PubMed ID: 35981390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of donor type and pre-transplant immunosuppression on outcomes of hematopoietic stem cell transplantation in children and young adults with severe aplastic anemia.
    Kashif R; Horn B; Milner J; Joyce M; Dalal M; Lee JJ; McNerney K; Cline J; Fort J; Castillo P; Galvez J; Alperstein W; Ligon J; Ziga E; Crawford D; Chellapandian D
    Pediatr Transplant; 2024 Jun; 28(4):e14784. PubMed ID: 38766976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparable survival outcome between transplantation from haploidentical donor and matched related donor or unrelated donor for severe aplastic anemia patients aged 40 years and older: A retrospective multicenter cohort study.
    Zhang YY; Mo WJ; Zuo YY; Zhou M; Zhang XH; Wang Y; Li YM; Zhang YP; Chen YH; Chen XW; Mo XD; Wang CX; Lin F; Huang XJ; Wang SQ; Xu LP
    Clin Transplant; 2020 Mar; 34(3):e13810. PubMed ID: 32011059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between haploidentical hematopoietic stem cell transplantation combined with an umbilical cord blood unit and graft-
    Yao D; Tian Y; Li J; Li B; Lu J; Ling J; Zheng D; Yao Y; Xiao P; Meng L; Hu S
    Ther Adv Hematol; 2022; 13():20406207221134409. PubMed ID: 36324490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Haploidentical hematopoietic stem cell transplantation for patients with myeloid sarcoma: a single center retrospective study.
    Yu WJ; Sun YQ; Han TT; Ye PP; Zhang XH; Xu LP; Liu KY; Yan CH; Huang XJ; Wang Y
    Ann Hematol; 2021 Mar; 100(3):799-808. PubMed ID: 33416901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haploidentical hematopoietic stem cell transplantation as a first-line treatment for paediatric severe aplastic anemia: a single-center research.
    Yuan M; Jia C; Ma J; Zhang M; Zhu G; Wang B; Zheng J; Qin M; Wu R; Li S
    Int J Med Sci; 2024; 21(6):1027-1036. PubMed ID: 38774762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of a 2-arm, phase 2 clinical trial using post-transplantation cyclophosphamide for the prevention of graft-versus-host disease in haploidentical donor and mismatched unrelated donor hematopoietic stem cell transplantation.
    Gaballa S; Ge I; El Fakih R; Brammer JE; Kongtim P; Tomuleasa C; Wang SA; Lee D; Petropoulos D; Cao K; Rondon G; Chen J; Hammerstrom A; Lombardi L; Alatrash G; Korbling M; Oran B; Kebriaei P; Ahmed S; Shah N; Rezvani K; Marin D; Bashir Q; Alousi A; Nieto Y; Qazilbash M; Hosing C; Popat U; Shpall EJ; Khouri I; Champlin RE; Ciurea SO
    Cancer; 2016 Nov; 122(21):3316-3326. PubMed ID: 27404668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
    Blaise D; Fürst S; Crocchiolo R; El-Cheikh J; Granata A; Harbi S; Bouabdallah R; Devillier R; Bramanti S; Lemarie C; Picard C; Chabannon C; Weiller PJ; Faucher C; Mohty B; Vey N; Castagna L
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):119-24. PubMed ID: 26341397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparisons of unmanipulated haploidentical donor, unrelated cord blood donor and matched unrelated donor hematopoietic stem cell transplantation in pediatric acquired severe aplastic anemia: a single center study.
    Lu Y; Xiong M; Sun RJ; Zhang JP; Zhao YL; Wei ZJ; Cao XY; Zhou JR; Liu DY; Lu DP
    Leuk Lymphoma; 2022 Dec; 63(14):3307-3316. PubMed ID: 36067518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical analysis of 76 patients with severe aplastic anemia treated with haploid hematopoietic stem cell transplantation].
    Zhang Y; Zhang GX; Pang AM; Yang DL; Zhang RL; Zhai WH; Wei JL; He Y; Jiang EL; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Mar; 44(3):202-210. PubMed ID: 37356981
    [No Abstract]   [Full Text] [Related]  

  • 33. [HLA- haploidentical donor hematopoietic transplantation for severe aplastic anemia achieved comparable outcomes with HLA- unrelated donor transplantation].
    Lu Y; Wu T; Cao X; Zhao Y; Liu D; Sun R; Xiong M; Wei Z; Zhang J; Zhou J; Lu D
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jan; 37(1):35-8. PubMed ID: 26876251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
    Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant.
    Xu LP; Jin S; Wang SQ; Xia LH; Bai H; Gao SJ; Liu QF; Wang JM; Wang X; Jiang M; Zhang X; Wu DP; Huang XJ
    J Hematol Oncol; 2017 Jan; 10(1):25. PubMed ID: 28107815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of different styles of allogeneic hematopoietic stem cell transplantation as first-line treatment treated with severe aplastic anemia in children and adolescents].
    Yang SW; Ma RJ; Zhao JJ; Zhong HF; Yuan XL; Jiang L; Yang J; Lei PC; Zhang Y; Fu YW; Wan DM; Zhu ZM
    Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):184-189. PubMed ID: 29562461
    [No Abstract]   [Full Text] [Related]  

  • 37. The Case for Upfront HLA-Matched Unrelated Donor Hematopoietic Stem Cell Transplantation as a Curative Option for Adult Acquired Severe Aplastic Anemia.
    Marsh JCW; Risitano AM; Mufti GJ
    Biol Blood Marrow Transplant; 2019 Sep; 25(9):e277-e284. PubMed ID: 31129354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Haploidentical and matched unrelated donor allogeneic hematopoietic stem cell transplantation offer similar survival outcomes for acute leukemia.
    Wang YC; Lai CL; Chen TC; Gau JP; Teng CJ
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2060. PubMed ID: 38600053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparable clinical outcomes of haploidentical hematopoietic stem cell transplantation in patients with hepatitis-associated aplastic anemia and non-hepatitis-associated aplastic anemia.
    Ma X; Zuo Y; Xu Z; Zhang Y; Cheng Y; Han T; Suo P; Sun Y; Tang F; Wang F; Yan C; Chen Y; Wang Y; Zhang X; Liu K; Huang X; Xu L
    Ann Hematol; 2022 Aug; 101(8):1815-1823. PubMed ID: 35739427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peritransplantation Glucocorticoid Haploidentical Stem Cell Transplantation Is a Promising Strategy for AML Patients With High Leukemic Burden: Comparison With Transplantations Using Other Donor Types.
    Kaida K; Ikegame K; Inoue T; Maruyama S; Ishii S; Uchida N; Doki N; Eto T; Fukuda T; Katayama Y; Takada S; Kawakita T; Ichinohe T; Atsuta Y; Daimon T; Ogawa H
    Transplant Cell Ther; 2023 Apr; 29(4):273.e1-273.e9. PubMed ID: 36641032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.